Clinical trials recruiting for Squamous Cell Lung Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| C-CAR031 | 1 |
| GPC3 and/or TGFβ targeting CAR-T cells | 1 |
| ZEN003694 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New Jersey | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of ZEN003694 in People With Squamous Cell Lung Cancer
- APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
- An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer
- GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
Related conditions
Trials recruiting for Squamous Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Squamous Cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.